Estepan Ian Michael 4
4 · Sarepta Therapeutics, Inc. · Filed Mar 3, 2026
Insider Transaction Report
Form 4
Estepan Ian Michael
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-03-01+8,125→ 208,875 total - Tax Payment
Common Stock
[F2]2026-03-02$16.20/sh−3,301$53,476→ 205,574 total - Tax Payment
Common Stock
[F3]2026-03-02$16.20/sh−875$14,175→ 204,699 total - Exercise/Conversion
Performance Stock Units
[F1]2026-03-01−8,125→ 0 total→ Common Stock (8,125 underlying)
Footnotes (3)
- [F1]Represents the number of shares previously earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The shares vested on March 1, 2026.
- [F2]Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of a PSU award granted on March 1, 2024.
- [F3]Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 1, 2024.
Signature
/s/ Cristin L. Rothfuss, as Attorney-in-Fact for Ian Michael Estepan|2026-03-03